Ansa Biotechnologies
Berkeley, CA
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
https://ansabio.com/Company Details
Founded
- 2018
Employees
- Between 10 - 100 employees
Raised
- $83,419,680
Headquarters Location
- Berkeley, CA
Public
- No
Acquired
- No
CEO
Jason T. Gammack
Founders
- Sebastian PallukJared EllefsonDaniel Lin-Arlow
Company Collections
These are collections Ansa Biotechnologies is a part of. Click on the collection name to view similar companies.
Ansa Biotechnologies' Investors
Ansa Biotechnologies' Industries
Ansa Biotechnologies' Tech Stack
Current Job Listings
Ansa Biotechnologies Headquarters Location
Total Amount Raised: $83,419,680
Ansa Biotechnologies' Investors
Ansa Biotechnologies Funding Rounds
Series A
$68,000,000
Series A Investors
Northpond VenturesCodon CapitalBlue Water Life Science FundCarbon Silicon VenturesMubadala Capital VenturesHorizons VenturesFiscus VenturesAltitude Life Science VenturesPEAK6Fifty YearsRA Capital ManagementHumboldt FundMei Z.Series Unknown
$5,000,000
Series Unknown Investors
Horizons VenturesHumboldt FundMubadala Capital VenturesGrant
$994,682
Grant Investors
National Science Foundation (NSF)Seed
$7,900,000
Seed Investors
Horizons VenturesMubadala Capital VenturesHumboldt FundY CombinatorGrant
$225,000
Grant Investors
National Science Foundation (NSF)Pre Seed
$1,300,000
Pre Seed Investors
Fifty Years
Ansa Biotechnologies Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ansa Biotechnologies.